Apyx Medical appoints Stavros Vizirgianakis as Executive Chairman
Apyx Medical Corporation appointed Stavros Vizirgianakis as Executive Chairman effective June 11, 2026, granting him 450,000 restricted stock units with no cash compensation. The appointment recognizes his service and expected contributions in providing strategic leadership and governance oversight.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day